Free Speech Challenges to the Inflation Reduction Act
This Viewpoint looks at the lawsuits brought by pharmaceutical companies to challenge the Inflation Reduction Act of 2022, in particular claims under the First
West Virginia United States Bristol Myers Squibb Aaron Kesselheim S Sean Tu Pubmedgoogle Scholarcrossref
Source: jamanetwork.com